(3 years, 7 months ago)
Commons ChamberI thank all the teachers in Vauxhall and the rest of the country for the work they are doing on online education as well as teaching children from the most vulnerable families and the children of our NHS and social care staff on the frontline. The hon. Member is right to highlight the issue. Some teachers—those who are clinically vulnerable, for example—will be captured in the nine cohorts set out for us by the Joint Committee on Vaccination and Immunisation, as will those in the right age groups in categories one to nine. I give her the commitment that as soon as we are through phase one, the priority absolutely will be to ensure that those who are critical to the functioning of the future of our country—the future generations to come—are prioritised.
I congratulate my hon. Friend on his excellent start. In Newbury, we are due to receive our first doses later this week. The issue is one of information. All my constituents want to know is when the doses will be received and when their loved ones can expect to be contacted. May I invite my hon. Friend to work with NHS England to ensure that timely local information is made readily available going forward?
I absolutely share my hon. Friend’s concern. I give her that commitment. The team at NHS England is working and focusing on giving as much time and notice as possible to primary care and hospitals on when they get deliveries, so they can make those appointments and keep vaccinating those who are most vulnerable. That is exactly its priority at the moment.
(3 years, 8 months ago)
Commons ChamberMy hon. Friend knows from personal experience what this disease can be like. He has been a powerful voice for Ashfield, and I will take his representations into account when we make a decision on Wednesday.
It is extremely concerning that more than 1,000 cases of the new variant have been identified in the south-east, but I understand that the vaccine still works. Data published by the ONS today shows that the mortality rate will fall by 84% when all over-70s are vaccinated. Could my right hon. Friend tell the House when he thinks that will be and what it will mean for the tiering system?
Believe me, I would love to be able to answer that question. We do not know, because it depends on the speed of manufacture of the vaccines and the approval or not of the Oxford vaccine by the MHRA. But the essence of the way that my hon. Friend asks the question is exactly how we are thinking about it in Government.
(3 years, 10 months ago)
Commons ChamberI, too, congratulate my hon. Friend the Member for Sevenoaks (Laura Trott) on bringing this Bill to the House, and it is a delight to speak in the debate this morning, because I recall talking to her about it in the very early days after we were elected. I am glad it is now being ventilated on Second Reading in this Chamber.
I am part of the cohort of Members who was unaware that it was lawful to inject fillers and botox into the faces of children under the age of 18. When I began my research, I was struck that the first case study I found was of a young British girl whose mother was a part-time beauty therapist who entered her into pageants. She was injecting this eight-year-old with a full face of botox before every performance and every competition. If that example was extreme, it did not take very long to find much less extreme examples and to see how ubiquitous the issue was.
VICE magazine did an experiment in 2019 with a 16-year-old girl where they visited 20 beauty salons in Essex and London, and every single one was willing to make the appointment for either botox or filler. They did not ask the young girl to produce any ID. The conclusion of VICE was that it did not particularly matter whether they went to a Harley Street practitioner in an upmarket venue or a high street hair salon where the filler was administered alongside the leg waxing kit in the back room—the reaction was the same.
Of the 20 salons, only 13 bothered to take any details about next of kin or who her GP was. In a sense, they were off-the-books procedures. When the British Association of Aesthetic Plastic Surgeons—BAAPS, as it is more commonly known—was asked about that, its director was very clear, saying that treatments of this nature carry physical and psychological side effects and that most registered practitioners should not contemplate giving them to teenagers. Yet the simple truth is that the light-touch regulation means there is ample opportunity for unscrupulous practices.
My hon. Friend has just given a horrific account of what an eight-year-old girl went through in beauty pageants. May I just ask her where the research came from and how she got access to that information? It seems to me that the negative impacts out there are not prevalent, and that they will be overridden by the positive impacts that this is going to have.
I must confess to my hon. Friend that I found that particular story in the scientific tome that is the Daily Mail. I must also confess that when the details of that particular mother came to light and her story was reported, the child was at least temporarily taken into care. That is probably not a surprise to any Member.
I would like to give three reasons for supporting the Bill. The first relates to something that my hon. Friend the Member for Sevenoaks touched on: the skyrocketing number of botched procedures. In 2018, approximately 610 botched treatments of this nature were reported; that had more than doubled by 2019.
This sounds awful. I am learning by sitting here and listening to this. Has anyone died as a result of these procedures? Apart from perhaps medically, has anyone been affected mentally and committed suicide? Have these procedures killed anyone?
I am not aware of any case where somebody has, but I am happy to take an intervention on that point. However, focusing on personal injury, we can probably all agree that this is an area of law that is ripe for change, regardless of whether a child has actually died from a complication.
I will proceed for a moment and give way in due course.
Two points about the personal injury element are particularly pertinent. The first is that the very act of injecting filler or botox into a young and developing face has potentially serious medical consequences in and of itself. The second is that if it does go wrong, the impact, not just physically but psychologically, could be so much more serious than for an adult. My hon. Friend the Member for Sevenoaks gave the example of a young 15-year-old girl who nearly lost her lips; imagine the trauma that surrounds that.
The force of the Bill is not just in its creation of an offence of injecting a filler or botox into an under-18-year-old, but in the scope of the defence set out in clause 2(4)—the reasonably onerous requirement for a practitioner to show that they took “all reasonable precautions” and conducted “due diligence” in establishing the age of their patient before they administered the treatment. The Bill does not just have the effect of creating an offence if the practitioner fails to do that; as my hon. Friend the Member for East Surrey (Claire Coutinho) said, by introducing such a regulation, it brings insurance into the frame and creates a right to make a claim for personal injury against a practitioner—a claim for damages should personal injury arise—in a case of this nature.
The second reason why I support the Bill is that it implicitly recognises the undesirable psychological impact of children embarking on invasive cosmetic procedures. This goes so much further than a manicure or a haircut; it is the beginning of a teenager, basically, changing their face. They do it because of a three-pronged assault that they face: from celebrities, from people who participate in reality TV shows, and from social media. I have to say that I think Instagram is particularly pernicious in this regard.
That is why the Bill dovetails so neatly with the ten-minute rule Bill introduced by my hon. Friend the Member for Bosworth (Dr Evans). When they are taken together, they are more than the sum of their parts, because they recognise that young people face a barrage of photographs of women with an unattainable standard of beauty, where the woman herself has probably been doctored and the image certainly has, too. These young people, at a stage in their lives when they are impressionable, vulnerable and at their least assured of their own identities, are fed a tacit message that it is not just desirable but necessary to adhere to that standard of beauty.
My hon. Friend is making a fantastic speech. She is raising issues around social media. Does she not agree that there are also concerns over broadcasters and that they, too, have a responsibility? Does she share my concerns over the so-called “Love Island” effect? Young children and teenagers watching such programmes are looking at body images that are so far removed from reality that they do great damage not only physically but mentally.
I could not agree more with my hon. Friend and I thank him for that point. I was talking about celebrities, reality TV shows and social media sites, but the fact is that they are completely blended as mediums. Someone who appears in one will also be present on the other.
In reality TV shows such as “Love Island”, it is not just the women who are put on pedestals as perfect specimens, but the young men, too. We must not ignore that young men often feel lacking in confidence as well when they see programmes like that. It is important that we stress that.
I am grateful to my hon. Friend for her point, which I agree with. I have focused my comments more on young women, but I think the read-across to men should not be disregarded.
We must not forget that celebrities are people, too. They feel the anxiety and pressure to conform, too. That creates a vicious cycle. Spencer Matthews, very honourably, has spoken about the need to use steroids to bulk up and Laura Anderson has spoken about the need to manipulate her images put into the media so that they conform to a standard. Does my hon. Friend agree that that is part of the problem? There is a vicious cycle of trying to achieve something unobtainable.
I agree with my hon. Friend. This is not a case of trying to pinpoint individuals and say that they are responsible; it is an overall culture.
I have reflected on what this says to young women. It does not say that it is a good idea to look that way. It says that it is a necessary idea to look that way if you want to be happy and successful, and to have a partner, to have a full social life and to be of value in this world. And actually it says that the opposite, not conforming to those kinds of standards, is equivalent to failure. That is a pernicious message that deserves to be aired by Members of the House this morning.
I am just going to make a little bit of progress, but I will give way when I finish my next point.
The third reason why I support the Bill concerns young people’s mental health. There will not be a Member sitting in the House today who is not aware of the explosion in young people’s mental health problems. One piece of research I looked at was by the Mental Health Foundation, which took place 18 months ago. It found that one in four teenage girls aged 16 to 19 suffered from a mental health disorder sufficiently serious that they had either self-harmed in some way or made an attempt on their life. That is 25% of 16-to-19-year-old women. Within that particular cohort there was an overwhelming incidence of those young women also spending quite extended periods of time on social media. What were they doing? They were looking at images of other young women, contrasting themselves and drawing out what they perceived to be their own inadequacies.
I support the Bill and I congratulate my hon. Friend the Member for Sevenoaks again, not just because of the physical protections it puts in place for children under 18, but also for criminalising the conduct of dodgy therapists. Most fundamentally, I support the Bill for what we as a society say to teenage girls about their worth and their wellbeing.
I wanted to pick up on a point made by my hon. Friend, which she went on to cover in her speech. There may not be mortality statistics per se, but my own view, having spent a lot of time with that age group, is that, as she has pointed out, there is a serious issue with suicide. The 25% statistic she gave is frightening.
My hon. Friend makes the point elegantly. It is probably difficult to draw a direct line from a child who would like to have, or has had, a botox procedure to somebody who ends up taking their own life, attempting to do so or contemplating doing so, but perhaps those feelings and the lack of self-worth, exacerbated by their youth and the pressures upon them, are all part of the same causal root.
(3 years, 11 months ago)
Commons ChamberWe have strong protocols on the return to school. I am really glad about the success of the policy to get all schools back; it is one of the Government’s unsung successes over recent weeks, and is working effectively. The guidelines set out very clearly when testing is appropriate. Testing is appropriate for people who have symptoms. Close contacts of people who have symptoms need to self-isolate and not get a test unless they have symptoms because getting a test would not allow them to leave self-isolation anyway because of the risk of false negatives. That is why the policy is as it is. We have given each school 10 or more tests so that they can easily use them in an emergency, and that has been warmly welcomed by most schools.
A successful return to school in west Berkshire has been matched with a reduction in the availability of testing. I have listened to my right hon. Friend this morning; if there is a reluctance to impose more stringent eligibility criteria, would he consider an order of priority based on, for example, working parents and teachers being able to access tests sooner?
Again, there has not been a reduction in capacity in Berkshire or anywhere else in the country. There has been an increase in capacity. My hon. Friend makes a good point, though, about prioritisation. The question is how to enforce prioritisation without putting in place barriers that slow down access to tests for people who need them. We are looking at that now.
(4 years, 1 month ago)
Commons ChamberThose projections did not take into account the actions that the UK Government are undertaking.
I welcome the news today about the successful trial of the Oxford vaccine. The question on my constituents’ lips is: when will that be available on the market? I know my right hon. Friend cannot give those assurances, but could he assist my constituents first by saying when the trial is due to end, and secondly by giving assurances that the route to market for a successful vaccine will be as quick as that for dexamethasone?
On the first point, I am afraid that I cannot give my hon. Friend the clarity that she understandably seeks on behalf of her constituents, because it is a scientific question. As the rate of new infections has fallen, so the clinical trials have had to be a bit longer, because they are trying to prove a negative: that if someone has had the vaccine, they do not then get the disease. As a result, AstraZeneca has taken the vaccine around the world and put trials in countries where there is a much higher rate of infection. The rule with clinical trials is that, as soon as a trial comes to a conclusion that is beyond reasonable scientific doubt, the results are brought forward immediately. It is not a trial with a specific end date; it is a trial that runs until it is concluded scientifically, one way or the other. I hope that explanation—well, it is not as good as a date, but I hope that people accept it.
On the second point, my hon. Friend is absolutely right. We have been working hand in glove with these brilliant scientists, and we should put it on the record, even though it might take me an extra 30 seconds to say it, Mr Deputy Speaker, that the Medicines and Healthcare Products Regulatory Agency has done an amazing job. Alongside the scientists, it has made sure the trials are designed so that it can approve the results as soon as the results come forward—essentially, in parallel, rather than afterward, which is the norm. The MHRA has played a blinder; it is one of the reasons that the UK is at the forefront in vaccines and treatments. That means the vaccine will be available as soon as humanly possible as soon as the science is proven.
(4 years, 2 months ago)
Commons ChamberOf course it has been necessary to have tight controls over visitors in hospitals during this crisis, because people picking up nosocomial infections in hospital has been one part of the epidemic that we need to get under control. My heart goes out to those many people who have made sacrifices, including the hon. Member’s constituent, and of course we always keep this under review.
My hon. Friend makes an important point. She may have seen this morning that in Germany, North Rhine-Westphalia has been put back into lockdown because of a local outbreak. So far, the local outbreaks we have seen have essentially been clusters in very small areas, and we have been able to bust those clusters and tackle them. We do, of course, hold the powers to have wider local lockdowns. Those will be based on judgments based on the epidemiological advice and advised by the joint biosecurity centre, working with all the relevant agencies.
(4 years, 2 months ago)
Commons ChamberI would like to begin by congratulating my right hon. Friend on the successful roll-out of dexamethasone, but my question is about international comparison. We were one of the later countries to be hit by the virus. There are others who have begun the process of moving out of lockdown ahead of us. What countries does my right hon. Friend see as the paradigm for the United Kingdom, and what steps, if any, are we taking to share information with healthcare professionals to emulate best practice?
This is a great question, and we look all the time for countries around the world that we can learn from. It is true that, in terms of where we were on the epidemiological curve, we went into lockdown before many European countries—before Germany, Spain and Italy—with lower cases per million. But we still learned from them. For instance, one of the lessons from Germany is that a massive testing regime is incredibly important, and we now have a much bigger testing regime than Germany, which is terrific, and we have built that up. We also look to the far east, with its lessons from severe acute respiratory syndrome and middle east respiratory syndrome, which it learned more directly. It has the contact tracing which we are putting in place. We are constantly learning. Probably the single most important thing that we can do in this crisis is constantly look around the world for places where we can learn best practice, and then implement it here.
(4 years, 3 months ago)
Commons ChamberUrgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
The more people who download the app the better it will be and the more effective it will be in keeping people safe. However, even small numbers downloading it will help us to spot hotspots and so will bring some value. I was really delighted yesterday afternoon to hear from Isle of Wight Radio, which stated that 80% of people on the Isle of Wight in an early survey said that they wanted to download the app. That would be a terrific result. I pay tribute to the work of Isle of Wight Radio and the local press on the Isle of Wight, who have taken to Isle of Wight’s important role in piloting this roll-out with enthusiasm. There is no numerical answer to the hon. Gentleman’s question. The answer is that as many as possible will make us as safe as possible.
I welcome the launch of the test, track and trace app, but one of the apparent challenges is that those who could benefit from it the most, namely the elderly, may be those who are least likely to be able to access it because they do not have a smart phone. What assessment has my right hon. Friend made of the probable lower take-up by that honourable cohort?
We have looked into this very important question. Of course, test, track and trace is a system. The app is one part of it, but the human contact traces are an important part of the system, as is the advice we give to people to contact their own significant contacts themselves. The whole system has been designed knowing that a proportion of the population does not have a smart phone. There are many older people who do have smart phones. I am sure, for instance, that the shadow Secretary of State is probably sending a message to his parents right now on the smart phone he is using instead of listening to my hon. Friend’s question. There is a serious point, which is that of course we have had to take that into account. It is another reason why the Isle of Wight is such a good place to trial it, because there are elderly residents on the Isle of Wight. We will work out and learn a lot from how effective that trial is.
(4 years, 7 months ago)
Commons ChamberWith your permission, Mr Speaker, I will answer Questions 1, 4, 6, 11 and 20 together. [Interruption.] General practice is a popular subject.
We will create an extra 50 million appointments a year in primary care so that everyone can go to the GP when they need to.
Yes. My hon. Friend has already become an incredibly strong voice for Wolverhampton, and it was a pleasure to visit Tettenhall medical practice, which has joined with other GP practices to form a primary care network, which I hope will strengthen its resilience and enable it to provide extended access to appointments, which is what he is campaigning for. I am pleased, too, with the extra 16,000 appointments in Wolverhampton in the last quarter. As this shows, we are driving up the number of appointments, but we also appreciate, understand and feel the frustration people feel when they cannot get decent access to GP appointments.
Changes to pension contributions mean that some senior GPs, including in Newbury, are being hit with extra tax charges if they work overtime, which is leading to the paradoxical situation of GPs paying to work and so reducing their hours or taking early retirement. What steps is the Secretary of State’s Department taking to address this situation?
Tax is, of course, a matter for the Treasury, and the Chancellor would not be thrilled if I announced tax policy in the middle of health questions, tempting as that may be. However, we have been working with the Treasury, and also with the Academy of Medical Royal Colleges, the British Medical Association, employers in the NHS and others, to deliver on our manifesto commitment to sort this out.